secwatch.observer — SEC 8-K summary
======================================

Issuer:     OCULAR THERAPEUTIX, INC (OCUL)
CIK:        0001393434
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001104659-22-072151
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocular Therapeutix shareholders approve 3.6M share increase under 2021 Stock Incentive Plan
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2021 Stock Incentive Plan, increasing authorized shares by 3,600,000.
- Elected Seung Suh Hong, Richard L. Lindstrom, and Leslie J. Williams as Class II directors until 2025.
- Non-binding advisory vote on executive compensation passed: 31,197,580 for, 10,723,248 against.
- Ratified PricewaterhouseCoopers as independent auditor for fiscal 2022 with 60,017,922 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1393434/000110465922072151/0001104659-22-072151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1393434/000110465922072151/tm2218753d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-072151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer